5Huyhes AK, Stricklett PK, Kohan D. Cytotoxic effect of shiga toxin-1 on human proximal tubule cells. Kidney Int, 1998,54:4265 Geet CV, Proesmans W, Arnout J et al. Activation of coagulation and fibrinolysis in childhood hemolytic uremic syndrome. Kidney Int, 1998, 54:1324.
4Tsai HM. The molecular biology of thrombotic microangi-opathy[J]. Kidney International, 2006,70 ( 1 ) : 16.
5Fang CJ,Richarcls A,Liszewski MK,et al. Advances in understanding of pathogenesis of aHUS and HELLP[J]. Br J Haematol,2008,143(3):336.
6Sandoval JA,Sheehan MP,Stonerock CE,et al. Incidence,risk factors, and treatment patterns for deep venous thrombosis in hospitalized chil- dren:an increasing population at risk[J]. J Vasc Surg,2008,47(4): 837-843.
7胡亚美,诸福堂.实用儿科学[M].7版.北京:人民卫生出版社,2002:1174
8Cochran JB, Panzarino VM, Maes LY, et al. Pneumococcus - induced T -antigen activation in hemolytic uremic syndrome and anemia [J]. Pediatr Nephrol, 2004 : 317 - 321.
9Boyer O, Niaudet P. Hemolytic uremic syndrome : new developments in pathogenesis and treatment [J]. Int J Nephrol, 2011.
10Caletti MG, Lejarraga H, Kelmansky D, et al. Two different therapeutic regimes in patients with sequelae of hemolytic uremic syndrome [J]. Pediatr Nephrol, 2004, 19 (10): 1148-1152.
